[{"id":3088,"name":"Elekta showcases China’s growing role in radiotherapy at ninth CIIE","url":"https://ir.elekta.com/investors/newsroom/2026/elekta-showcases-chinas-growing-role-in-radiotherapy-at-ninth-ciie/","date":"2026-11-11T14:20:00.000Z","intro":"
The ninth China International Import Expo (CIIE) in Shanghai brought together three important milestones for Elekta: progress in bringing adaptive radiotherapy into routine clinical practice, clinical experience from more than 15,000 patients treated with Elekta Unity in China, and the 1,000th linear accelerator delivered from the Beijing facility.
","regulatory":false},{"id":3086,"name":"Invitation to the presentation of Elekta’s second quarter 2026/27","url":"https://ir.elekta.com/investors/press-releases/2026/invitation-to-the-presentation-of-elektas-second-quarter-202627/","date":"2026-11-11T06:30:00.000Z","intro":"STOCKHOLM – Elekta will host a presentation of its second quarter 2026/27 results on November 25 at 10:00 a.m. CET. The presentation will be broadcast live via webcast, with the option to join by telephone. The interim report for the second quarter will be published at 7:30 a.m. CET on the same day.
","regulatory":false},{"id":3082,"name":"What new clinical research tells us about the direction of adaptive radiotherapy","url":"https://ir.elekta.com/investors/newsroom/2026/what-new-clinical-research-tells-us-about-the-direction-of-adaptive-radiotherapy/","date":"2026-11-06T10:05:00.000Z","intro":"Research presented at the 2026 MR-Linac Consortium Meeting covered a wide range of developments in MR-guided radiotherapy. Among the research presented, three studies using Elekta Unity explored whether treatment volumes can be reduced to limit radiation exposure to healthy tissue, whether treatment can involve fewer visits and how treatment plans can be adapted in more complex cases.
","regulatory":false},{"id":3080,"name":"Elekta’s Nomination Committee for the Annual General Meeting 2027","url":"https://ir.elekta.com/investors/press-releases/2026/elektas-nomination-committee-for-the-annual-general-meeting-2027/","date":"2026-10-30T06:30:00.000Z","intro":"STOCKHOLM – Elekta’s (EKTA-B.ST) Nomination Committee for the Annual General Meeting 2027 has been appointed in accordance with the instructions for the Nomination Committee adopted by the Annual General Meeting 2024.
","regulatory":true},{"id":3076,"name":"How MR-guided radiotherapy is supporting more individualized pediatric care in Mexico","url":"https://ir.elekta.com/investors/newsroom/2026/how-mr-guided-radiotherapy-is-supporting-more-individualized-pediatric-care-in-mexico/","date":"2026-10-02T07:45:00.000Z","intro":"In pediatric radiotherapy, what clinicians can see during treatment can shape the decisions they make in the room. Pediatric cancer presents unique challenges. Children's bodies are still developing, and while treating the tumor effectively is essential, protecting healthy tissues is equally important. Every millimeter matters. Every treatment decision can influence not only survival, but also long-term quality of life.
","regulatory":false}]